Browse 156 HPV clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
HPV is so common that most sexually active people get it at some point, and the body usually clears it without anyone knowing. When it lingers, certain types can cause cancer years later, including more than 90 percent of cervical cancers and most cancers of the throat. A vaccine that prevents these infections has been available since 2006. The vaccine does not treat an infection that is already there, and trials are testing therapeutic vaccines and treatments that clear HPV and precancer before it becomes cancer.
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
for
Papillomavirus Vaccines
Location: Gainesville FL
Sponsor: University of Florida
Sex: All
Age: 8 - 70+
Code: NCT06535139
Recruiting
Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
for
Oropharynx Cancer, Stage I
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT06254911
Phase 2, Recruiting
A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment
for
Head and Neck Cancer
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT07179315
Phase 2, Recruiting
Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer
for
Oropharyngeal Cancer
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT07290621
Phase 2, Recruiting
STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision
for
Vulvar Cancer
Location: Vancouver
Sponsor: British Columbia Cancer Agency
Sex: Female
Age: 18+
Code: NCT05576831
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: South Portland ME, Boston MA, New Haven CT,
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06064877
Phase 3, Recruiting
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
for
Oropharyngeal Carcinoma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06984861
Phase 2, Recruiting
Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
for
Oropharyngeal Squamous Cell Carcinoma
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT04852328
Phase 2, Recruiting
Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma
for
Head and Neck Cancer, Oropharyngeal Squamous Cell Carcinoma
Location: London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Sex: All
Age: 18+
Code: NCT04220749
Phase 2, Recruiting
Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
for
Oropharyngeal Cancer, Carcinoma
Location: Los Angeles CA, Beverly Hills CA, Torrance CA,
Sponsor: Zachary Zumsteg
Sex: All
Age: 18+
Code: NCT06445114
Phase 2, Recruiting
Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly
for
Oropharynx Cancer, Frailty
Location: Jacksonville FL
Sponsor: Omar Mahmoud
Sex: All
Age: 65 - 70+
Code: NCT06309225
Recruiting
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
for
Carcinoma of Unknown Primary,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03010150
Recruiting
Empowering Vietnamese Americans
for
HPV Vaccination, Cancer Prevention
Location: Lansing MI
Sponsor: Michigan State University
Sex: All
Age: 18+
Code: NCT07164391
Recruiting
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Pittsburgh PA, Irvine CA, Duarte CA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07156227
Phase 1, Recruiting
New
CHAMPION: A Study to Evaluate the Efficacy and Safety of Obudanersen (ION582) in Children and Adults With Angelman Syndrome (AS)
for
Angelman Syndrome
Location: Carrboro NC
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All
Age: 2 - 50
Code: NCT07782827
Phase 3, Recruiting
Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment
for
Cervical Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center